Sanders Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12B Buy
5,067,740
+906,550
+22% +$251M 1.12% 28
2026
Q1
$1.23B Sell
4,161,190
-16,325
-0.4% -$4.85M 1.46% 25
2025
Q4
$1.14B Buy
4,177,515
+450,760
+12% +$122M 1.31% 25
2025
Q3
$1.01B Buy
+3,726,755
New +$1.01B 1.24% 27

Other funds holding CME

Sanders Capital's CME Position: Q2 2026 in Review

Sanders Capital increased its CME Group (CME) stake by 22% in Q2 2026, buying an estimated $251M and bringing the position to 5,067,740 shares worth $1.12B. The position accounts for 1.12% of the portfolio, ranked #28.

Sanders Capital first reported a position in CME in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.23B in Q1 2026. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Sanders Capital held 5,067,740 shares of CME Group worth $1.12B as of Q2 2026.
  • Sanders Capital bought 906,550 CME Group shares in Q2 2026, an estimated $251M.
  • CME Group made up 1.12% of Sanders Capital's portfolio in Q2 2026, its #28 holding.
  • Sanders Capital first reported a position in CME Group in Q3 2025 and has held it in 4 quarters since.
  • Sanders Capital's CME Group position peaked at $1.23B in Q1 2026.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sanders Capital's 13F filing for Q2 2026, filed 10 Aug 2026.